The radiosensitizer 2-benzoyl-3-phenyl-6,7-dichloroquinoxaline 1,4-dioxide induces DNA damage in EMT-6 mammary carcinoma cells
<p>Abstract</p> <p>Background</p> <p>DCQ (2-benzoyl-3-phenyl-6,7-dichloroquinoxaline 1,4-dioxide), a synthetic quinoxaline 1,4-dioxide, enhances the cytotoxic effect of ionizing radiation (IR) <it>in vivo </it>and <it>in vitro</it>. We sought to...
Main Authors: | Smith Colin A, Haddadin Makhluf J, Geara Fady, Haykal Joelle, Gali-Muhtasib Hala |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-07-01
|
Series: | Radiation Oncology |
Online Access: | http://www.ro-journal.com/content/4/1/25 |
Similar Items
-
Radiosensitization by 2-benzoyl-3-phenyl-6,7-dichloroquinoxaline 1,4-dioxide under oxia and hypoxia in human colon cancer cells
by: Haddadin Makhluf, et al.
Published: (2007-01-01) -
Cell death by the quinoxaline dioxide DCQ in human colon cancer cells is enhanced under hypoxia and is independent of p53 and p21
by: Haddadin Makhluf J, et al.
Published: (2010-11-01) -
(5-Benzoyl-3,6-dimethoxynaphthalen-2-yl)(phenyl)methanone
by: Yuichi Kato, et al.
Published: (2011-05-01) -
The Studies of Photodynamic Therapy in Migration of Murine Mammary Carcinoma EMT6 Cells and EMT6 Tumor-bearing Mice
by: Yu-Chen Chang, et al.
Published: (2014) -
Novel 2‑(5-Imino‑5H‑isoquinolones[3,4‑b]quinoxalin-7-ylmethyl)-benzonitrile (DIQ3) and Other Related Derivatives Targeting Colon Cancer Cells: Syntheses and in Vitro Models
by: Alissar Monzer, et al.
Published: (2019-02-01)